Driving impactful health improvements as a global leader in innovative and cost-effective rapid, near patient diagnostic test solutions.
Lumos Diagnostics Holdings Limited (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced its full year results including Appendix 4E and Annual Report to Shareholders for the fiscal year ending on 30 June 2021. MORE
FY21 RESULTS BRIEFING
LETTER FROM OUR BOARD CHAIR AND CEO
FY21 ANNUAL REPORT
Australia: 1300 040 690
Outside Australia: +61 3 9415 4100
Investor-related questions? Get in touch!